Gefitinib

Gefitinib ATC Code L01EB01 : Antineoplastic and immunomodulating agents - Antineoplastic drugs - Protein kinase inhibitors - Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors - Gefitinib
Gefitinib
LatinGefitinibum
RoutesOral
FDA Approval Date2003-05-05
Molecular FormulaC22H24ClFN4O3
Molecular Weight446.91 g/mol
CAS Number184475-35-2
Brand namesIressa

Gefitinib list of brand/trade names

  • Germany: Iressa
  • France: Iressa
  • Italy: Iressa
  • Australia: Iressa
  • Poland: Iressa
  • Denmark: Iressa
  • Turkey: Iressa


ATC Codes

  1. Alimentary tract and metabolisma
  2. Blood and blood forming organs
  3. Cardiovascular system
  4. Dermatological drugs
  5. Genitourinary system and reproductive hormones
  6. Systemic hormonal preparations, excluding reproductive hormones and insulins
  7. Antiinfectives for systemic use
  8. Antineoplastic and immunomodulating agents
  9. Musculoskeletal system
  10. Nervous system
  11. Antiparasitic products, insecticides and repellents
  12. Respiratory system
  13. Sensory organs
  14. Various ATC structures

The newly added categories

  1. Tivozanib
  2. Fedratinib
  3. Tucatinib
  4. Everolimus
  5. Abemaciclib
  6. Selumetinib
  7. Gefitinib
  8. Minoxidil
  9. Diclofenac
  10. Mecillinam